Cargando…
Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
BACKGROUND: The incidence of colorectal cancer (CRC) is on the rise. Furthermore, late-stage diagnoses and limited efficacious treatment options make CRC a complex clinical challenge. Therefore, a new therapeutic regimen with a completely novel therapeutic mechanism is necessary for CRC. In the pres...
Autores principales: | Yin, Lei, Zhao, Chunhong, Han, Jixia, Li, Zengjun, Zhen, Yanan, Xiao, Ruixue, Xu, Zhongfa, Sun, Yanlai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308569/ https://www.ncbi.nlm.nih.gov/pubmed/28223815 http://dx.doi.org/10.2147/TCRM.S128575 |
Ejemplares similares
-
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo
por: Fan, Jingjing, et al.
Publicado: (2021) -
Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo
por: Schwertner, Barbara, et al.
Publicado: (2021)